cyclopentane has been researched along with Communicable Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZJ; Skaug, B | 1 |
| GOZSY, B; KATO, L | 2 |
| MAHNERT, E | 1 |
4 other study(ies) available for cyclopentane and Communicable Diseases
| Article | Year |
|---|---|
SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
Topics: Allosteric Regulation; Bacterial Toxins; Communicable Diseases; Cyclopentanes; Cytokines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Heat-Shock Proteins; Hemolysin Proteins; Heterocyclic Compounds, 3-Ring; Humans; NEDD8 Protein; Neoplasms; Nuclear Proteins; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; Tankyrases; Transcription Factors; Ubiquitin; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Ubiquitin-Protein Ligases; Ubiquitination; Ubiquitins | 2010 |
Studies on the effects of phagocytic stimulation on microbial disease. V. Stimulation of phagocytic activity of monocytes against tubercle bacilli, strain BCG.
Topics: Bacillus; Communicable Diseases; Cyclopentanes; Histamine; Histamine Agents; Humans; Lacticaseibacillus casei; Monocytes; Mycobacterium bovis; Mycobacterium tuberculosis; Phagocytosis | 1956 |
Studies on the effects of phagocytic stimulation on microbial disease. VI. Some factors decreasing phagocytic acitivity of monocytes against tubercle bacilli, strain BCG.
Topics: Bacillus; Communicable Diseases; Cyclopentanes; Histamine; Histamine Agents; Histamine H1 Antagonists; Humans; Lacticaseibacillus casei; Monocytes; Mycobacterium bovis; Mycobacterium tuberculosis; Phagocytosis | 1956 |
[Clinical experience with p-methoxyphenyl-dithio-cyclopentene-thione in viral hepatitis].
Topics: Communicable Diseases; Cyclopentanes; Hepatitis; Hepatitis A; Heterocyclic Compounds; Thiones; Viral Vaccines | 1957 |